Background. There have been few studies of earlier systematic intervention to reduce the impact of acute kidney injury (AKI). In 2009, we piloted an AKI outreach service with a before and after study, and we report on the study and its longer-term follow-up. Methods. AKI patients were identified using a laboratory delta check for creatinine of 75%. In the 4-week before phase patients received standard care. In a consecutive 7-week after phase an outreach team of nephrology doctors and nurses reviewed all alerts twice daily, 5 days a week. The primary clinical team caring for the patient was called to be given advice on AKI care. Results. There were 157 and 251 patients in the before and after groups, respectively, who were comparable in their characteristics. The mean age was 70 years in both groups and ∼80% of each group were admitted to the hospital. In the after group, the Outreach telephone call was successful in 88%, at a median of 14 h. Substantial numbers of recommendations were made, largely related to fluid balance, investigations and medication use. Survival showed an immediate non-significant improvement in the after group, but converged at about 4 years. Conclusion. Outreach shows potential to improve outcomes in AKI. In order to achieve this it seems likely that at least a five-day per week service will be needed to assist good renal and general medical care for this vulnerable group.
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I N T R O D U C T I O N
Acute kidney injury (AKI) is a common condition among hospital inpatients [1, 2] , tending to affect elderly comorbid patients and result in high mortality. There has been increasing realization over the last decade that the care of these patients is often suboptimal [3, 4] . This in turn is likely due to a combination of factors, including delayed recognition/referral of AKI and the difficulties in dealing with these complex patients. Even with an increase in referrals in the last decade or so, only a minority of AKI cases are discussed with nephrologists, with the majority not being referred. When referral does occur it is often delayed. It is now well known that late referral to nephrology is associated with poorer outcome both in general inpatients [5, 6] and critical care patients [7] .
The chief method of diagnosing AKI for the bulk of patients is from a rise in serum creatinine. Biomarkers such as cystatin C or neutrophil gelatinase-associated lipocalin have yet to be widely used, perhaps due to cost and uncertainty about their utility. The advent of computerized warnings, or 'alerts', by laboratory information systems has brought the potential for earlier recognition of AKI. In a prospective audit of such alerts from 2008, we found that their use was feasible [8] . A prognostic index, applied to alert patients, showed promise in predicting survival. We felt that the use of alerts could be combined with an AKI outreach service, to intervene earlier in the course of AKI. Therefore, we carried out an evaluation of such a service, using a before and after design, to study this complex multifactorial intervention.
M E T H O D S
The evaluation of an AKI outreach service was conducted as a prospective before and after study. We studied the first episodes of AKI in adults aged 16 years and older, commencing within the study time period, as indicated by an 'alert' from the pathology system. The alert messaging system was set up within the Integrated Clinical Environment (ICE) pathology management software (Sunquest Information Systems [Europe] Ltd), used by two of the hospitals in our group (one of ∼720 beds, one of 250 beds), and the large majority of primary care practices in our area. The 'catchment' population which is provided renal services by this trust is estimated at ∼850 000 adults. According to National Research Ethics Service procedures, the project was classified as a service evaluation by the Heart of England NHS Trust Research and Development office and did not require separate ethical approval.
Alert system
The system sent an alert for any result, which showed a ≥75% rise in creatinine from the previous creatinine value recorded for that patient (a 'delta check'). This value was chosen for initial AKI detection as being feasible, as demonstrated in our work [8] . The previous creatinine was the value immediately prior to the alert creatinine, and the former was at any time point in the past ranging from the same day to years before. It is not identical to a baseline creatinine and will be called 'previous creatinine' below. No imputed baseline values were used. The peak creatinine was the highest creatinine during the episode of AKI [1, 9] . The RIFLE stage [10] for each patient was determined using the percent rise from baseline to peak creatinine for the episode of AKI. This was determined retrospectively. Our laboratory takes part in the National External Quality Assessment Service (NEQAS) adjustment of the Modification of Diet in Renal Disease 4-variable equation, using an isotope dilution mass spectrometry traceable version of the equation, and with NEQAS-derived slope adjustors to the equation.
Before study Alerts were prospectively collected for 4 weeks between 09:00, 15 May 2009 and 17:00, 12 June 2009 (28.3 days, Figure 1 ). As in our previous study, during this 'before' period, no intervention was made. Patient referral was entirely at the discretion of their primary care or hospital clinician. Referred patients were managed in the usual way by the nephrology team. There was no publicity regarding the study, and clinicians in the before phase were unaware of the study.
After study From 17:00, 12 June 2009, until 17:00, 31 July 2009 (49 days), all alerts were collected for review by an AKI outreach team in working hours. The team consisted of nephrologists (consultants and senior trainees) and senior nephrology nurses. All were experienced in dealing with AKI and received specific AKI training prior to the outreach evaluation. During the seven-week after study, the team reviewed new alerts on the ICE system twice daily, 5 days a week. All weekend alerts were reviewed on Monday. The outreach team member contacted the clinical team responsible for the patient, either a doctor or trained ward nurse. Details of the patient and the conversation were recorded on a standardized form, and advice given to the patient's clinical team were recorded. When possible this form was also faxed to the clinical team. Advice was given in these areas:
(i) Fluid balance and volume assessment (including urine output measurement with catheterization as needed)
(ii) Investigation (urinalysis, ultrasound and other investigations) (iii) Medication (cessation or avoidance of nephrotoxic agents; dose adjustment when needed) (iv) General medical management (including sepsis management, nutritional assessment and physiotherapy) (v) Care pathway (including admission, inpatient transfer and outpatient assessment as required) (vi) Escalation and palliative care (advice on escalation to critical care, and end of life care decisions).
Data collection and statistical analysis
After discharge, the electronic patient record was reviewed for all patients. Categorical variables were compared using the χ 2 -test; continuous variables were compared using the Mann-Whitney test or t-test, as appropriate. A count of preexisting malignant or non-malignant, non-renal modified Charlson comorbidities [8] was included in our analysis. Patient follow-up was concluded in April 2014, when the vital status of all remaining survivors was checked. For each patient with repeat episodes of AKI, only the first eligible AKI episode was used in the survival data.
F I G U R E 1 : Before and after evaluation of AKI outreach service.
R E S U LT S

Alerts
The median [Interquartile range (IQR)] time interval between the previous and alert creatinines was 35 (7-170) and 51 days for the before and after groups, respectively (P = 0.67, Mann-Whitney test). In the before study, from 264 alerts there were 157 first episodes of AKI identified in adult patients. In four patients in the before group, a further AKI episode was identified during that phase. A total of 103 further false alerts were excluded on review (see below).
In the after study, from 361 alerts there were 251 first episodes of AKI identified in adult patients. A total of 101 further false alerts were excluded on review. In six patients who were included in the before group, a further AKI episode was identified during the after phase. Three patients in the after phase had repeat episodes of AKI identified. These nine episodes were eligible for an outreach call, so 260 alerts in 259 patients were eligible for one or more outreach calls. In both phases, there were approximately five true alerts per day, 7 days a week (data not shown). In the before and after phases, respectively, 24 and 22% of the first alerts were for patients in the community at the time of the blood test (a small number were later admitted).
Across the two phases, the reasons for the 204 'false alerts' were similar to our previous work: identification of haemodialysis patients (n = 144); repeat alerts for the same AKI episode (20) ; patient already on haemodialysis at time of alert (15); suppressed previous creatinine value (13); alerts in children (4) and other reasons (8) .
Comparison of before and after groups The characteristics of the before and after group are shown in Table 1 . The groups were comparable in their clinical characteristics. As might be expected the patients were older, with considerable comorbidity. In the before and after groups, 35.7 and 35.9%, respectively, had an estimated GFR <60 mL/min/ 1.73 m 2 , calculated from the previous creatinine. The ≥75% delta check produced similar proportions of patients with stages R, I and F AKI (equivalent to stages 1-3). The nature of the delta check excludes patients with smaller rises in creatinine (≥26 µmol/L or 0.3 mg/dL) now designated stage 1 AKI. Few patients had acute-on-chronic kidney disease in the before and after phases (0.6 and 2.0%, respectively), due to the requirement for a ≥75% rise in creatinine. The use of haemodialysis was comparable in both groups.
Outreach calls in after phase
In the after study, 260 AKI episodes were eligible for AKI outreach. Of these, completed outreach calls were made in 229 (88.1%); 12 patients were deceased before the call could be made (4.6%); in 8 patients no contact could be made with the primary clinical team (3.1%); in 7 patients there was insufficient outreach time (2.7%) and in 4 cases (1.5%), the patient was referred for nephrology review before or at the time of the call.
Interventions made during the outreach call
The outreach call for the 229 successful contacts was made at a median (IQR) time after the alert of 14.6 (3.8-19.8) hours. A median (IQR) of three (two to four) specific recommendations were made and recorded on the outreach form. The details of the recommendations are shown in Table 2 . Larger numbers of recommendations were made regarding investigations, volume or fluid management and drugs. General medical recommendations were required in a minority of patients.
Outcomes
There was no difference in peak creatinine between the groups. There was a non-significant reduction in length of stay of a little 
O R I G I N A L A R T I C L E
O u t r e a c h f o r a c u t e k i d n e y i n j u r y over half a day in the after group. The patients in the after phase showed a modest improvement in survival, compared with those in the before phase, initially about 6%. This difference appeared rapidly and was initially sustained during follow-up (Figure 2) , with a later attenuation of any survival benefit (P = 0.38, log rank test).
D I S C U S S I O N
AKI is rarely a monophasic illness arising from a single insult over a limited time, but more often occurs as a result of multiple insults over time. The natural history is that over one-half of patients progress from one stage to a more severe stage [13] , allowing opportunities to interrupt progression. The related concept of critical care outreach has been developed in conjunction with early warning scores for inpatients over the last decade or so. However, the results of the major studies [14, 15] and systematic reviews [16, 17] have shown inconclusive results. AKI outreach differs from critical care outreach, in that for the former the 'afferent limb' (the initial warning of deterioration) is automated. In addition, the number of AKI patients across healthcare systems is substantial. Studies using the narrower RIFLE definition [10] or wider AKIN definition [18] found that 15 to 18% [1, 2] of hospital inpatients developed AKI. There has been little work on systematic real-time intervention to ameliorate the progression of AKI. One group studied the use of alerts restricted to intensive care patients [19] . Another group studied early intervention for inpatients in a small Veterans Hospital. In a non-consecutive before and after study (n = 85 and 91, respectively), the severity of AKI was significantly reduced [20] . The intervention was delivered at an average of 13 h after the biochemical alert. Alerts have been successfully introduced into UK hospitals [21, 22] . A national algorithm for detection of AKI with alerts is being introduced in 2014 [23] . However, the evidence for a beneficial impact of alerts on outcomes in kidney disease is conflicting [19, [24] [25] [26] . The benefits of alerts are perhaps better established in reducing nephrotoxic medication use [27, 28] . Alerts sent to busy clinicians 'in isolation' can have limited effectiveness [29] , perhaps partly due to alert over-riding [28, 30, 31] and alert fatigue. We reasoned that earlier specialist contact, largely by telephone, with the primary clinical team would improve care for large numbers of patients with AKI across our healthcare system. It was possible to gather data and deliver an AKI outreach service for 7 weeks. The nature of the intervention delivered will not surprise clinicians who regularly treat AKI patients. In part, it corrects for well-known difficulties in medical care for AKI [3] . Thus our intervention covered AKIspecific fluid balance, investigation and drug advice. In addition, it included general medical, pathway and escalation decision advice. The drug changes showed a similar pattern to other AKI studies. The need for better end of life care has been recognized as an issue in critical care outreach [32] , but has been little researched in AKI patients.
Our alert system used a simple 'delta check' looking for a ≥75% rise in creatinine, without any use of a baseline within a particular timeframe. The choice of this level of delta check is pragmatic but arbitrary. With this consecutive before and after study, the two groups were comparable. Any particular threshold for an alert will result in a mixed group of patients with varying stages of AKI, as the severity of the AKI remains to be seen at the time of the first alert. Lowering the threshold produces an exponential rise in the daily numbers of alerts (data not shown). As with early warning scores for critical care outreach, an arbitrary threshold is chosen, aiming to limit the outreach responses to higher risk patients. The best 'threshold' for alerts to trigger nephrology referral or outreach intervention has yet to be determined, in relation to the KDIGO definition of AKI [29, 33] .
We dealt with large numbers of alerts over a 7-week period in a complex healthcare system, but were able to deliver the intervention to almost 90% of patients, at an average of 14 h after the alert. Our study did not show any reduction in AKI severity, as shown by the peak creatinine. We found a non-significant initial improvement in survival in the after group, maintained over initial follow-up. The survival effect then appeared to become attenuated at ∼4 years. The improved survival appeared immediately, consistent with an effect due to the intervention. Measures to tackle the underlying cause(s) of AKI and improve the general condition of the patient may be as important as 'AKI-specific' measures.
Strengths of our study include it being representative of the AKI patients who present across healthcare and included patients in the community. The before and after studies were consecutive, so our results are unlikely to be explained by a secular trend with improvements in AKI care. Our work shows that AKI outreach can be delivered to reasonable numbers of patients with resources that will be feasible for many healthcare systems. Studies of complex multifactorial interventions such as ours have inherent limitations. It is difficult to dissect out the component(s) of the intervention responsible for any benefit. Although our study was more than double the size of the one other similar study, a more extensive trial is needed [34] .
A limitation of the study was the limited time available for the outreach team. A full-time working hours team may achieve a larger impact. More sophisticated alerts, perhaps combined with other prognostic indicators [8] , may allow outreach teams to focus on patients most likely to benefit from the intervention. If nephrology finds the holy grail of a drug to reduce ischaemic acute tubular injury, such an outreach service seems likely to be rapidly adopted. Until then the main justification for AKI outreach could include reductions in length of stay, the development of end-stage renal disease, as well as mortality. A larger cluster randomized trial of sufficient power will be needed to study these possible benefits.
